A new study adds to a growing set of evidence that women who use hormonal birth control have higher rates of breast cancer, but experts have stressed that the overall risk remains low.

October is a critical time to spotlight the latest innovations in medical devices designed to improve breast cancer diagnosis ...

Today we have two new segments in our "Chasing Cancer" series, and later we'll hear from Dr. Steven Rosenberg from the National Cancer Institute.

CNW/ – Servier Canada is pleased to announce the approval and commercial availability of VORANIGO™ (vorasidenib tablets), the first targeted therapy for the treatment of Grade 2 isocitrate ...

Enter Cologuard, the at-home colon cancer screening test for people aged 45 and older. Perhaps best known by audiences for its cheeky approach to advertising, the Exact Sciences brand recently ...

Thrivers, survivors and “pinkwashing” dominate October campaigns. What’s missing is education about the disease, those being ...

Integration of Telemedicine Consultation Into a Tertiary Radiation Oncology Department: Predictors of Use, Treatment Yield, and Effects on Patient Population Of the 960 patients with cancer who ...

A new report on breast cancer carries positive news, and negative news, and the negative is getting far more attention, ...

“PBMs, through a variety of ‘spread pricing’ programs, have historically driven pharmacy reimbursement for dispensed generic medications in all payer segments – commercial ... said Mark Fleury of the ...

North America Cancer Diagnostics Market Size Set Expands at Significant CAGR of 6.11% During 2024-2030 to Reach USD 23.48 Billion by 2030 Request To Download Free Sample of This Strategic Report @ ...

We acknowledge and mourn the loss of about 42,250 women who will lose their lives to breast cancer this year (statistics from the American Cancer Society). Littlewhale / stock.adobe.com We turn our ...

Arriving at the luxury house two years after Karl Lagerfeld, he helped guide a boom in both products and revenues as ...